Publikationen 2004 und früher

Download nur für den persönlichen Gebrauch. Vergewissern Sie sich vor dem Download, dass das Manuskript nicht durch Urheberschafts- oder andere Rechte geschützt ist und unterlassen ansonsten den Download. Im Zweifelsfall kontaktieren Sie bitte das entsprechende Journal.

 

 

2004

 
     
 

 

Looyenga B, Beuschlein F, Nilson J, Hammer GD.
Mechanistic roles of inhibin as a tumor suppressor in the adrenal cortex.
Endocr Res; 2004 30(4):585-6

 

 

pubmed

 

 

Zwermann O, Beuschlein F, Klink A, Stahl M, Reincke M.
The role of the ACTH receptor in adrenal tumors: Identification of a novel microsatellite marker.
Horm and Met Res; 2004 36(6):406-10

 

pubmed

 

 

Reincke M, Ortmann D, Hausmann J, Beuschlein F.
Cytotoxic T-cell Response against Steroidogenic Acute Regulatory Protein using DNA Vaccination Followed by Vaccinia Virus Infection in a Mouse Adrenal Carcinoma Model.
Horm and Met Res; 2004 36(6):411-4

 

pubmed

 

 

Beuschlein F, Looyenga BD, Reincke M, Hammer GD.
Role of the inhibin / activin system and luteinizing hormone in adrenocortical tumorigenesis
Horm and Met Res; 2004 36(6):392-6

 

pubmed

 

 

Slawik M, Reisch N, Zwermann O, Maser-Gluth C, Stahl M, Klink A, Reincke M, Beuschlein F.
Characterization of an Adrenocorticotropin (ACTH) Receptor Promoter Polymorphism Leading to Decreased Adrenal Responsiveness to ACTH.
J Clin Endocrinol Metab; 200489(7):3131-7

 

pubmed

(Editorial )

 

Schirpenbach C, Seiler L, Beuschlein F, Reincke M.
Primary aldosteronism: diagnosis and differential diagnosis.
J Lab Med;2004 28(2):135–143

 

 

 

Ortmann D, Hausmann J, Beuschlein F, Schmenger K, Stahl M, Geissler M, Reincke M.
Steroidogenic acute regulatory protein is a potential target for vaccination-based immunotherapy in adrenocortical carcinomas.
Endocrinology; 2004 145(4):1760–1766

 

pubmed

 

 

2003

 
     
 

 

Saeger W, Fassnacht M, Chita R, Prager G, Nies C, Lorenz K, Bärlehner E, Simon D, Niederle B, Beuschlein F, Allolio B, and Reincke M.
High diagnostic accuracy of adrenal core biopsy: Results of the German Adrenal Network multicenter trial in 220 consecutive patients
Human Pathol; 2003 34(2):180-186

 

 

pubmed

 

Beuschlein F, Looyenga BD, Bleasdale, S, Mutch C, Bavers DL, Parlow A, Nilson JH, Hammer GD.
Activin induces x-zone apoptosis that inhibits luteinizing hormone-dependent adrenocortical tumor formation in inhibin deficient mice
Mol Cell Biol; 2003 23(11):3951-64.

 

pubmed

 

Beuschlein F, Looyenga BD, Reincke M, Giordano TJ, Hammer GD.
Clinical Impact of Recent Advances in the Biology of Adrenocortical Cancer
Endocrinologist; 2003 13(6):470-478

 

 

2002

 
     
 

 

Beuschlein F, Keegan CE, Bavers DL, Mutch C, Hutz JE, Shah S, Ulrich-Lai YM, Engeland WC, Jeffs B, Jameson JL, and Hammer GD
SF-1, DAX-1 and ACD: Molecular determinants of adrenocortical growth and steroidogenesis
Endocrine Research; 2002 28(4):597-607.

 

 

pubmed

 
 

Beuschlein F, Mutch C, Bavers DL, Ulrich-Lai YM, Engeland WC, Keegan C, Hammer GD.
Steroidogenic Factor-1 is Essential for Compensatory Adrenal Growth Following Unilateral Adrenalectomy
Endocrinology; 2002 143(8):3122-35.

 

pubmed

 
 

Beuschlein F, Hammer GD.
Ectopic POMC Syndrome
Endocrinol Metab Clin North Am; 2002 31(1):191-234.

 

pubmed

 
 

Babu PS, Bavers DL, Beuschlein F, Shah S, Jeffs B, Jameson JL, Hammer GD.
Interactions between Dax-1 and Steroidogenic Factor-1 in vivo: Increased adrenal responsiveness to ACTH in the absence of Dax-1
Endocrinology; 2002 143:665-673.

 

pubmed

 
 

2001

 
     
 

 

Wachenfeld C, Beuschlein F, Zwermann O, Mora P, Fassnacht M, Allolio B, Reincke M.
Discerning malignancy in adrenocortical tumors: are molecular markers useful?
Eur J Endocrinol;2001 145(3):335-41.

 

 

pubmed

 
 

Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M.
Angiotensin II type I receptor and ACTH receptor expression in human adrenocortical neoplasms.
Clin Endocrinol (Oxf.); 2001 54(5):627-632.

 

pubmed

 

Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M.
ACTH-Receptor - Expression, Regulation, and Role in Adrenocortical Tumor Formation
Eur J Endocrinol;2001 144(3):199-206.

 

pubmed

 

 

2000

 
     
 

 

Reincke M, Beuschlein F, Slawik M, Borm K.
Molecular adrenocortical tumourigenesis
Eur J Clin Invest; 2000 30(Suppl. 3):63-68.

 

 

pubmed

 

Fassnacht M, Hahner S, Beuschlein F, Klink A, Reincke M, Allolio B.
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line
Eur J Clin Invest; 2000 30(Suppl. 3):76-82.

 

pubmed

 

Beuschlein F, Reincke M, Königer M, D'Orazio D, Dobbie Z and Rump LC.

Cortisol Producing Adrenal Adenoma - a New Manifestation of Gardner's Syndrome

Endocr Res; 2000 26(4):783-790

 

pubmed

 

Beuschlein F, Strasburger CJ, Siegerstetter V, Moradpour D, Lichter P, Bidlingmaier M, Blum HE, Reincke M.

Acromegaly due to growth hormone secretion by a malignant B-cell lymphoma

N Engl J Med; 2000342(25):1871-6.

 

pubmed

 

Zwermann O, Beuschlein F, Mora P, Weber G, Allolio B, Reincke M.
Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.
Eur J Endocrinol; 2000, 142(6):689-695.

 

pubmed

 

Beuschlein F, Borgemeister M, Schirra J, Göke B, Fassnacht M, Allolio B, Reincke M.
Oral glucose tolerance testing but not intravenous glucose administration uncovers hyperresponsiveness of hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas
Clin Endocrinol (Oxf); 2000, 52(5):617-623.

 

pubmed

 

Zenkert S, Beuschlein F, Fassnacht M, Arlt W, Allolio B, Reincke M.
Steroidogenic acute regulatory (StAR) protein expression in human adrenocortical tumors.
Eur J Endocrinol; 2000,142(3):294-299.

 

 

pubmed

 

1999

 
     
 

 

Arlt W, Beuschlein F, Allolio B.

Nebennierenrindeninsuffizienz: Diagnostik und Therapie

Medizinische Klinik; 1999, 94(6):353-354.

 

 

pubmed

 

Beuschlein F, Arlt W, Allolio B.

Das Cushing-Syndrom: Diagnostik und Therapie

Medizinische Klinik; 1999, 94(6):279-280.

 

 

pubmed

 

1998

 
     
 

 

Beuschlein F, Schulze E, Mora P, Gensheimer HP, Maser-Gluth C, Allolio B, Reincke M.

Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors.

J Clin Endocrinol Metab; 1998, 83(7):2585-2588.

 

pubmed

 

Reincke M, Beuschlein F, Lalli E, Arlt W, Vay S, Sassone-Corsi P, Allolio B.

DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis.

J Clin Endocrinol Metab; 1998, 83(7):2597-600

 

pubmed 

 

Fassnacht M, Beuschlein F, Vay S, Mora P, Allolio B, Reincke M.
Aminoglutethimide suppresses adrenocorticotropin receptor expression in the NCI-h295 adrenocortical tumor cell line.
J Endocrinol; 1998, 159(1):35-42

 

pubmed

 

Reincke M, Beuschlein F, Menig G, Hofmockel G, Arlt W, Lehmann R, Karl M, Allolio B.
Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex.
J Endocrinol; 1998, 156(3):415-23

 

 

pubmed

 

1997

 
     
 

 

Babadjanova G, Allolio B, Beuschlein F, Chuchalin A, Reincke M. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus in the Russian population.

Metabolism; 1997, 46(2):121-2.

 

pubmed

 

Reincke M, Beuschlein F, Latronico AC, Arlt W, Chrousos GP, Allolio B. Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression.
Clin Endocrinol Oxf; 1997, 46(5):619-26.

 

pubmed

 

Reincke M, Mora P, Beuschlein F, Arlt, W, Chrousos GP, Allolio B.
Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implication for tumorigenesis.
J Clin Endocrinol Metab; 1997, 82(9):3054-8.

 

 

pubmed

 

1994

 
     
 

 

Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B.
Clonal composition of human adrenocortical neoplasms.
Cancer Res; 1994, 54(18):4927-32.

 

pubmed